EUVIMEDEUVIMED entdecken
Multizentrische Studie

In Situ Patch Test and Repeated Open Application Test for Fixed Drug Eruption: A Multicenter Study

Hélène Traineau, Brigitte Milpied, Angèle Soria, Haudrey Assier, Florence Tetart, Claire Bernier, Marie-Christine Ferrier Le Bouëdec, Gwendeline Gener, Flore Kurihara, Olivia Bauvin, Juliette Delauney, Emmanuelle Amsler und 7 weitere

The Journal of Allergy and Clinical Immunology: In Practice · 2024-02 · 12 (2) · 460-468

DOI: 10.1016/j.jaip.2023.10.021 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift The Journal of Allergy and Clinical Immunology: In Practice, 2024-02. Verfasst von Hélène Traineau und 18 weiteren Autor:innen. Beteiligte Einrichtung: Médecine Sorbonne Universiy, Dermatology and allergology department, Hôpital Tenon, Assistance Publique des Hôpitaux de Paris (AP-HP), Paris, France. Hauptthemen laut MEDLINE: Drug Eruptions, Hypersensitivity. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Few studies have evaluated allergy workup in fixed drug eruption (FDE) in a large population. OBJECTIVE: To evaluate the sensitivity of a standardized allergy workup for diagnosing the cause of FDE, with a focus on in situ repeated open application tests (ROATs). METHODS: In a retrospective multicenter study, we analyzed the practice of conducting a complete allergy workup for the etiological diagnosis of FDE. It consisted of 3 steps: in situ patch tests (PTs) for all cases except pure mucosal involvement, followed by in situ ROAT if in situ PT results were negative, and finally a drug challenge (DC). The in situ ROAT involved daily application of the suspected drug on a previously affected FDE site for 7 days. RESULTS: Of 98 suspected FDE cases, 61 patients (median age 61 y; male-to-female ratio 1.8) with a complete allergy workup were included. In 4 cases, even the DC yielded negative results. Among the remaining 57 patients with a positive workup, implicated drugs included paracetamol (12 cases), β-lactams (11 cases), imidazoles (9 cases, including 5 with metronidazole), nonsteroidal anti-inflammatory drugs (8 cases), iodinated contrast media (4 cases), cotrimoxazole (3 cases), and various other drugs in 10 patients. The diagnosis was confirmed by in situ PT in 17 of 54 cases (31.5%), in situ ROAT in 14 of 40 cases (35%) (with 4 cases showing remote reactivation of FDE sites), and DC in 26 cases. CONCLUSIONS: The sequential allergy workup involving successively in situ PT, in situ ROAT, and DC is a reliable and safe method for diagnosing the cause of FDE. In situ tests exhibited a sensitivity of over 50%.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug EruptionsHypersensitivityHumansMaleFemaleMiddle AgedPatch TestsAnti-Inflammatory Agents, Non-SteroidalTrimethoprim, Sulfamethoxazole Drug Combination

Stichwörter der Autor:innen

Drug challengeDrug patch testsFixed drug eruptionIn situ patch testsIn situ repeated open application test

Substanzen

Anti-Inflammatory Agents, Non-SteroidalTrimethoprim, Sulfamethoxazole Drug Combination

Autor:innen und Institutionen

  • Médecine Sorbonne Universiy, Dermatology and allergology department, Hôpital Tenon, Assistance Publique des Hôpitaux de Paris (AP-HP), Paris, France.
  • Centre hospitalo-universitaire (CHU) de Bordeaux, Dermatology department, Saint André hospital, Bordeaux, France.
  • Cimi-Paris Inserm 1135, AP-HP, Sorbonne University, Hôpital Tenon, Dermatology and allergology department, Paris, France.
  • Dermatology department, AP-HP, Henri Mondor hospital, Créteil, France.
  • Dermatology department, CHU de Rouen, Rouen, France.
  • Dermatology department, CHU de Nantes, Nantes, France.

Zitieren

APA

Traineau, H., Milpied, B., Soria, A., Assier, H., Tetart, F., Bernier, C., Le Bouëdec, M. F., Gener, G., Kurihara, F., Bauvin, O., Delauney, J., Amsler, E., Bara, C., Pelletier, F., Valois, A., Castelain, F., de Risi Pugliese, T., Hamelin, A., & Barbaud, A. (2024). In Situ Patch Test and Repeated Open Application Test for Fixed Drug Eruption: A Multicenter Study. The Journal of Allergy and Clinical Immunology: In Practice, 12(2), 460-468. https://doi.org/10.1016/j.jaip.2023.10.021

Vancouver

Traineau H, Milpied B, Soria A, Assier H, Tetart F, Bernier C, et al. In Situ Patch Test and Repeated Open Application Test for Fixed Drug Eruption: A Multicenter Study. The Journal of Allergy and Clinical Immunology: In Practice. 2024;12(2):460-468. doi:10.1016/j.jaip.2023.10.021

BibTeX
@article{Traineau2024,
  author = {Traineau, Hélène and Milpied, Brigitte and Soria, Angèle and Assier, Haudrey and Tetart, Florence and Bernier, Claire and Le Bouëdec, Marie-Christine Ferrier and Gener, Gwendeline and Kurihara, Flore and Bauvin, Olivia and Delauney, Juliette and Amsler, Emmanuelle and Bara, Corina and Pelletier, Fabien and Valois, Aude and Castelain, Florence and de Risi Pugliese, Tullia and Hamelin, Aurore and Barbaud, Annick},
  title = {In Situ Patch Test and Repeated Open Application Test for Fixed Drug Eruption: A Multicenter Study},
  journal = {The Journal of Allergy and Clinical Immunology: In Practice},
  year = {2024},
  volume = {12},
  number = {2},
  pages = {460--468},
  doi = {10.1016/j.jaip.2023.10.021}
}
Kostenlos starten →